# The Individual Therapy for Patients With Wilson's Disease

> **NCT03957720** · EARLY_PHASE1 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 400 (estimated)

## Conditions studied

- Wilson's Disease

## Interventions

- **DRUG:** DMPS
- **DRUG:** Penicillamine
- **DRUG:** DMSA
- **DRUG:** Zinc gluconate

## Key facts

- **NCT ID:** NCT03957720
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-15
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03957720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03957720, "The Individual Therapy for Patients With Wilson's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03957720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*